Psychopharmacology Bulletin is a trademark of MedWorks Media Global, LLC, Los
Angeles, CA. Psychopharmacology Bulletin is indexed in Index Medicus, EMBASE/Excerpta Medica, Psychological Abstracts, Current Contents, Science Citation Index, SCOPUS, and Biological Abstracts under Psychopharmacol Bull.
Psychopharmacology Bulletin is a peer-reviewed journal available through subscription only. Permission to reproduce articles in whole or part must be obtained in writing from the publisher. Opinions and views expressed by authors are their own and do not necessarily reflect the views of the MedWorks Media founder and publisher James M. La Rossa Jr., the editor Dr. Michael E. Thase, or the editorial
Copyright © 1964-2010 by MedWorks MediaGlobal, LLC.
All rights reserved. Printed in the United States.
Psychopharmacology Bulletin (USPS# 020-272, ISSN# 0048-5764) is published quarterly by MedWorks Media Global, LLC, 1756 2nd Street, Manhattan Beach CA. Psychopharmacology Bulletin academic supplements are published on demand.
Periodicals Postage Pending at Santa Monica, Ca, and at additional mailing offices.
Postmaster, send address changes to:
MedWorks Media Global
1756 2nd Street
Manhattan Beach CA, 90266
2010 One-year subscription rates:
Individuals $250; Institutions $325; Outside US $450
For subscriptions, please use the business reply card inside the parent journal or visit our Web site: www.psychopharmbulletin.com
Psychopharmacology Bulletin is a member of the Medscape Publishers’ Circle©, an alliance of leading medical publishers whose content is featured on Medscape. Readers of Psychopharmacology Bulletin can earn AMA PRA Category 1 credits based on selected articles from this journal at Medscape.com. Medscape is part of the WebMD Medscape Health Network for professionals.
While every effort has been made to ensure dosing and other information are presented
accurately in this publication, the ultimate responsibility rests with the prescribing physician. Neither the publisher, the sponsor, nor the authors can be held responsible for errors or for any consequences arising from the use of information contained herein. Readers are strongly urged to consult any relevant primary literature. No claims or endorsements are made for any drug or compound currently under clinical investigation.